Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06827262 · ClinicalTrials.gov registry record

Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain

A clinical trial of Chronic Low Back Pain and Vertebrogenic Pain Syndrome, sponsored by Boston Scientific Corporation.

Recruiting
Registry status
1,500
Enrollment target
15
Study locations

NCT06827262 is a study of Chronic Low Back Pain and Vertebrogenic Pain Syndrome that is actively recruiting participants, run by Boston Scientific Corporation. The registered enrollment target is 1,500 participants, above the 571-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (163% higher). The trial reports 15 study locations across 13 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06827262, a study of Chronic Low Back Pain and Vertebrogenic Pain Syndrome, is actively recruiting participants, sponsored by Boston Scientific Corporation.

RECRUITING
Registry status
1,500 participants
Enrollment target
15
Study locations

Study Summary

Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

Conditions Studied

Chronic Low Back Pain Vertebrogenic Pain Syndrome

Interventions

  • DEVICE Intracept™ Intraosseous Nerve Ablation

Study Locations (15)

Arizona

  • Flagstaff Bone & Joint - Flagstaff
  • Innovative Pain and Wellness - Phoenix

New York

  • New York Spine and Pain Specialists - Port Jefferson Station
  • University of Rochester - Rochester

California

  • MarinHealth Spine Institute - Larkspur

Connecticut

  • The Spine Wellness Center in Westport - Westport

District of Columbia

  • Washington Hospital Center - Washington D.C.

Idaho

  • North Idaho Day Surgery, LLC - Post Falls

Illinois

  • Illinois Bone and Joint Institute - Barrington

Kentucky

  • Commonwealth Pain and Spine - Lexington

Trial Details

FieldValue
Enrollment Target 1,500 participants
Start Date 2025-03-26
Est. Completion 2034-07

Sponsor

Boston Scientific Corporation

280 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT06827262

The ClinicalTrials.gov registry entry for NCT06827262 describes a study currently listed as recruiting, categorized as an unspecified phase. The registered enrollment target is 1,500 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 571-participant average among 71 other Chronic Low Back Pain trials with a reported enrollment target (163% higher). The listed sponsor is Boston Scientific Corporation, which has 280 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Chronic Low Back Pain appearing as the primary indexed condition, and to 1 intervention - of which Intracept™ Intraosseous Nerve Ablation is the first listed.

NCT06827262 reports 15 study locations spanning 13 distinct geographic areas - top geographies include Arizona, New York, California.

Frequently Asked Questions

What is clinical trial NCT06827262 about?

NCT06827262 is a clinical study titled "Intracept Minimally-invasive PROcedure for VErtebrogenic Back Pain". Compile real-world outcomes of commercially approved Intracept™ Intraosseous Nerve Ablation Systems in the treatment of patients diagnosed with vertebrogenic pain.

What is the current status of trial NCT06827262?

This trial is currently recruiting. The enrollment target is 1,500 participants. The study started on 2025-03-26. Estimated completion is 2034-07.

What conditions does trial NCT06827262 study?

This clinical trial studies the following conditions: Chronic Low Back Pain, Vertebrogenic Pain Syndrome.

What interventions are being tested in trial NCT06827262?

The interventions under investigation include: Intracept™ Intraosseous Nerve Ablation (DEVICE).

Who is sponsoring clinical trial NCT06827262?

This trial is sponsored by Boston Scientific Corporation, which has 280 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06827262 being conducted?

This trial has 15 study locations across Arizona, California, Connecticut, District of Columbia, Idaho. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Chronic Low Back Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Chronic Low Back Pain

All registered trials for this condition

Vertebrogenic Pain Syndrome

All registered trials for this condition

Arizona

All trials with a study site in Arizona

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.